{"text": "April 12 Drug developer C4X Discovery said on Monday it has signed an exclusive licensing deal worth up to 414 million euros ($492.12 million) with French drugmaker Sanofi to develop an oral therapy for treatment of inflammatory diseases.A unit of the London-listed company will get an upfront payment of 7 million euros and receive up to a further 407 million euros for potential development, regulatory and commercialisation milestones. ($1 = 0.8413 euros) (Reporting by Yadarisa Shabong in Bengaluru; Editing by Shounak Dasgupta)"}